Reviewer ' s report Title : Phase II trial of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma

@inproceedings{ReviewerS,
  title={Reviewer ' s report Title : Phase II trial of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma},
  author={}
}
    Title: Phase II trial of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma The authors described a prospective study of radiotherapy concurrent with low-dose CDGP+5-FU for esophageal cancer. CDGP was a platinum anticancer drug which developed in Japan. The… CONTINUE READING